With the support of GLP-1 weight loss medications, patients have achieved sustainable weight management
Ferrannini E, Mark M, Mayoux E
Eli Lilly Earnings Call Recap: Q1 2026 We just got done listening to the quarter one, 2026 Eli Lilly earnings call
5 Discussion SID is a frequent complication of GCs therapy, with limited guidance regarding optimal management strategies
All GLP-1RAs retain the capacity to activate the GLP-1 receptor (GLP-1R), thereby initiating intracellular signaling cascadesincluding cAMP accumulation, protein kinase A (PKA) activation, and PI3K/Akt pathway engagementunderlying their endocrine, metabolic, and neuroprotective effects [8]
For diabetes management, insulin and metformin have established safety records during breastfeeding